Clinical Trial Update: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults [Phase 4]

View source ↗

Summary

Phase 4 update reporting on long-term immunogenicity after boosting with a tick-borne encephalitis vaccine in adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Tick-borne encephalitis vaccine (Tick-borne encephalitis vaccine)

Snippet

Sponsor: Novartis | Conditions: Encephalitis, Tick-Borne | Phase 4 | Status: COMPLETED